Professional Financial Advisors, LLC Argenx Se Transaction History

Professional Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$272.01 - $353.03 $7,344 - $9,531	-27 Reduced 58.7%	19 $7,000
Q3 2021 Oct 19, 2021	SELL	$295.0 - $350.58 $336,595 - $400,011	-1,141 Reduced 96.12%	46 $14,000
Q2 2021 Jul 20, 2021	BUY	$257.11 - $319.92 $305,189 - $379,745	1,187 New	1,187 $370,000
Q4 2020 Jan 14, 2021	SELL	$248.13 - $308.36 $271,950 - $337,962	-1,096 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$215.51 - $272.51 $236,198 - $298,670	1,096 New	1,096 $272,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Professional Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Professional Financial Advisors, LLC with notifications on news.